Flolan and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flolan (epoprostenol sodium) and Revlimid (lenalidomide). Common drug interactions include back pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Flolan and Revlimid. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Flolan?

Flolan has active ingredients of epoprostenol sodium. eHealthMe is studying from 10,067 Flolan users. Check the latest studies of Flolan.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 20, 2026

11 people who take Flolan and Revlimid together, and have interactions are studied.

What are the common drug interactions of Flolan and Revlimid, by gender? *:

female:

Back pain
Contusion (a type of hematoma of tissue in which capillaries)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Feeling hot
Fluid overload (too much fluid in the blood)
Hyperhidrosis (abnormally increased sweating)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site swelling
Pain in extremity

male:

Dyspnoea (difficult or laboured respiration)
Haemoglobin decreased
Epistaxis (bleed from the nose)
Pain in extremity
Pneumonia
Refractory cancer (cancer that has not responded to treatment)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Peripheral swelling

What are the common drug interactions of Flolan and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea (difficult or laboured respiration)
Haemoglobin decreased
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Peripheral swelling
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Refractory cancer (cancer that has not responded to treatment)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)

60+:

Pain in extremity
Back pain
Rash erythematous (redness of the skin)
Epistaxis (bleed from the nose)
Flushing (the warm, red condition of human skin)
Influenza like illness
Neuropathy peripheral (surface nerve damage)
Vision blurred
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Surgery

What are the existing conditions these people have? *

Constipation: 6 people, 54.55%
Blood Glucose Fluctuation: 4 people, 36.36%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 18.18%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 18.18%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Lymphoma (cancer that begins in immune system cells): 1 person, 9.09%
Hyperglycemia (high blood sugar): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Flolan and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously